Cargando…
Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo
This study was designed to evaluate the synergism of two couples of antihypertensive drugs (amlodipine + telmisartan and amlodipine + candesartan) on blood pressure reduction in vivo by both SynergyFinder 3.0 and probability sum test. Spontaneously hypertensive rats were treated with intragastric ad...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944853/ https://www.ncbi.nlm.nih.gov/pubmed/36810974 http://dx.doi.org/10.1002/prp2.1064 |
_version_ | 1784892008728363008 |
---|---|
author | Xia, Tian Xu, Lu‐Lu Guo, Peng‐Yue Shi, Wan‐Ting Cheng, Yan‐Qiong Liu, Ai‐Jun |
author_facet | Xia, Tian Xu, Lu‐Lu Guo, Peng‐Yue Shi, Wan‐Ting Cheng, Yan‐Qiong Liu, Ai‐Jun |
author_sort | Xia, Tian |
collection | PubMed |
description | This study was designed to evaluate the synergism of two couples of antihypertensive drugs (amlodipine + telmisartan and amlodipine + candesartan) on blood pressure reduction in vivo by both SynergyFinder 3.0 and probability sum test. Spontaneously hypertensive rats were treated with intragastric administration of amlodipine (0.5, 1, 2, and 4 mg/kg), telmisartan (4, 8, and 16 mg/kg), candesartan (1, 2, and 4 mg/kg), nine combinations for amlodipine and telmisartan, and nine combinations for amlodipine and candesartan. The control rats were treated by 0.5% carboxymethylcellulose sodium. Blood pressure was recorded continuously up to 6 h after administration. Both SynergyFinder 3.0 and the probability sum test were used to evaluate the synergistic action. The synergisms calculated by SynergyFinder 3.0 are consistent with the probability sum test both in two different combinations. There is an obviously synergistic interaction between amlodipine and telmisartan or candesartan. The combinations of amlodipine and telmisartan (2 + 4 and 1 + 4 mg/kg) and amlodipine and candesartan (0.5 + 4 and 2 + 1 mg/kg) might exert an optimum synergism against hypertension. Compared with the probability sum test, SynergyFinder 3.0 is more stable and reliable to analyze the synergism. |
format | Online Article Text |
id | pubmed-9944853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99448532023-02-23 Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo Xia, Tian Xu, Lu‐Lu Guo, Peng‐Yue Shi, Wan‐Ting Cheng, Yan‐Qiong Liu, Ai‐Jun Pharmacol Res Perspect Original Articles This study was designed to evaluate the synergism of two couples of antihypertensive drugs (amlodipine + telmisartan and amlodipine + candesartan) on blood pressure reduction in vivo by both SynergyFinder 3.0 and probability sum test. Spontaneously hypertensive rats were treated with intragastric administration of amlodipine (0.5, 1, 2, and 4 mg/kg), telmisartan (4, 8, and 16 mg/kg), candesartan (1, 2, and 4 mg/kg), nine combinations for amlodipine and telmisartan, and nine combinations for amlodipine and candesartan. The control rats were treated by 0.5% carboxymethylcellulose sodium. Blood pressure was recorded continuously up to 6 h after administration. Both SynergyFinder 3.0 and the probability sum test were used to evaluate the synergistic action. The synergisms calculated by SynergyFinder 3.0 are consistent with the probability sum test both in two different combinations. There is an obviously synergistic interaction between amlodipine and telmisartan or candesartan. The combinations of amlodipine and telmisartan (2 + 4 and 1 + 4 mg/kg) and amlodipine and candesartan (0.5 + 4 and 2 + 1 mg/kg) might exert an optimum synergism against hypertension. Compared with the probability sum test, SynergyFinder 3.0 is more stable and reliable to analyze the synergism. John Wiley and Sons Inc. 2023-02-22 /pmc/articles/PMC9944853/ /pubmed/36810974 http://dx.doi.org/10.1002/prp2.1064 Text en © 2023 The Authors. Pharmacology Research & Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Xia, Tian Xu, Lu‐Lu Guo, Peng‐Yue Shi, Wan‐Ting Cheng, Yan‐Qiong Liu, Ai‐Jun Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo |
title | Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo |
title_full | Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo |
title_fullStr | Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo |
title_full_unstemmed | Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo |
title_short | Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo |
title_sort | synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using synergyfinder 3.0 and probability sum test in vivo |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944853/ https://www.ncbi.nlm.nih.gov/pubmed/36810974 http://dx.doi.org/10.1002/prp2.1064 |
work_keys_str_mv | AT xiatian synergismofamlodipineandtelmisartanorcandesartanonbloodpressurereductionbyusingsynergyfinder30andprobabilitysumtestinvivo AT xululu synergismofamlodipineandtelmisartanorcandesartanonbloodpressurereductionbyusingsynergyfinder30andprobabilitysumtestinvivo AT guopengyue synergismofamlodipineandtelmisartanorcandesartanonbloodpressurereductionbyusingsynergyfinder30andprobabilitysumtestinvivo AT shiwanting synergismofamlodipineandtelmisartanorcandesartanonbloodpressurereductionbyusingsynergyfinder30andprobabilitysumtestinvivo AT chengyanqiong synergismofamlodipineandtelmisartanorcandesartanonbloodpressurereductionbyusingsynergyfinder30andprobabilitysumtestinvivo AT liuaijun synergismofamlodipineandtelmisartanorcandesartanonbloodpressurereductionbyusingsynergyfinder30andprobabilitysumtestinvivo |